Israel Englander Aptevo Therapeutics Inc. Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.17 - $0.38 $17,783 - $39,751	104,608 New	104,608 $18,000
Q1 2021 May 17, 2021	SELL	$27.86 - $40.59 $173,567 - $252,875	-6,230 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$6.21 - $48.36 $38,688 - $301,282	6,230 New	6,230 $228,000
Q3 2020 Nov 16, 2020	SELL	$7.21 - $9.37 $251,859 - $327,312	-34,932 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.11 - $9.27 $108,638 - $323,819	34,932 New	34,932 $292,000

Ticker APVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,090,640
Market Cap $24.5M
Description
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.